![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2025
Mair, Maximilian J.; Hartenbach, Sabrina; Tomasich, Erwin; Maas, Sybren L. N.; Bosch, Sarah A.; Widhalm, Georg; Eckert, Franziska; Sahm, Felix; Hainfellner, Johannes A.; Hartenbach, Markus; Berghoff, Anna S.; Preusser, Matthias und Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624
(2025):
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 52, Nr. 8: S. 2771-2781
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0953-7624
(2025):
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 52, Nr. 8: S. 2771-2781
[PDF, 2MB]
2018
Hartenbach, Markus; Weber, Stefan; Pilz, Magdalena; Hartenbach, Sabrina; Zacherl, Mathias J.; Paprottka, Philipp M.; Tiling, Reinhold; Bartenstein, Peter; Hacker, Marcus; Haug, Alexander R. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma.
In: Clinical Nuclear Medicine, Bd. 43, Nr. 7: S. 477-481
[PDF, 288kB]
ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma.
In: Clinical Nuclear Medicine, Bd. 43, Nr. 7: S. 477-481
[PDF, 288kB]